CME Chart

1 Month

	Date	Diff
	2025-05-02	+1.21 %
The article discusses a Phase I clinical trial evaluating the safety and preliminary effectiveness of AMG 404, a monoclonal antibody targeting PD-1, in patients with advanced solid tumors, where no dose-limiting toxicities were observed and notable antitumor activity was reported. The CME Group (CME) stock may have increased by 1.21% due to positive market sentiment related to its performance or relevant news that could indicate growth potential, but specific reasons were not provided in the article itself.
	2025-05-01	+0.01 %
CME Group (CME) stock rose by 0.01% despite insider selling by Director Dennis Suskind, who sold 1,000 shares, as reported in an SEC filing. The stock may have increased due to overall market conditions or investor sentiment that did not react negatively to the insider sale.
	2025-04-29	+1.66 %
CME Group (CME) stock rose by 1.66% despite board member Larry G. Gerdes selling 4,000 shares, likely due to positive market sentiment or other factors unrelated to the insider sale.
	2025-04-25	+1.15 %
CME Group's stock increased by 1.15% following Barclays' report raising its price target from $279.00 to $283.00, indicating a potential upside, alongside positive earnings results that beat analyst estimates. The CME Group (CME) stock rose by 1.15% due to positive market sentiment following the announcement of the launch of XRP futures and the easing of regulatory pressures on crypto reporting for banks by the Fed.
	2025-04-24	+0.68 %
CME Group's stock rose by 0.68% following comments from Cleveland Fed President Beth Hammack, who emphasized the need for patience in assessing the impact of tariffs on inflation and growth, amid expectations that the Federal Reserve will likely maintain interest rates before potentially cutting them in the coming months, reflecting positively on investor sentiment. CME Group's stock rose by 0.68% following the announcement that it will introduce XRP futures next month, pending regulatory approval, which reflects growing interest and potential institutional adoption of XRP. The increase in CME Group's stock is attributed to the anticipation surrounding the launch of XRP futures, indicating a positive market sentiment for XRP and the prospect of enhanced institutional investment opportunities. CME Group's stock rose 0.68% due to a combination of strong quarterly earnings that exceeded analyst estimates, multiple broker upgrades to buy ratings, and positive changes in analysts' price targets.
	2025-04-21	-0.84 %
CME Group (CME) stock fell by 0.84% likely due to broader market influences or investor sentiment towards related instruments like bitcoin futures, given the activity in the ProShares Bitcoin ETF (BITO), which reflects investor adjustments in response to market conditions. CME Group (CME) stock declined by 0.84% due to macroeconomic instability stemming from the US-China trade war, which is causing volatility in the markets and impacting investor sentiment negatively. CME Group's stock declined by 0.84% as it approached its quarterly earnings announcement scheduled for April 23rd, amid mixed analyst evaluations and recent insider stock sales indicating potential corporate sentiment concerns.
	2025-04-17	+0.44 %
The CME Group's stock rose by 0.44% amid broader market movements, including a decline in the ProShares Bitcoin & Ether Equal Weight ETF, which could be influenced by the recent acquisition of shares by an institutional investor, indicating interest in cryptocurrency-related investments.
	2025-04-15	-0.31 %
CME Group (CME) stock is down by 0.31% amid concerns regarding the overall market environment and potential adverse economic indicators or developments affecting investor sentiment. CME Group Inc. (NASDAQ:CME) saw its stock decline by 0.31%, despite analysts raising their Q4 2025 earnings estimates, likely due to mixed ratings from various brokerages and recent insider selling activity.
	2025-04-10	+1.68 %
The article discusses the recent 1.68% increase in CME Group (CME) stock, which can be attributed to an optimistic outlook from George Tsilis regarding Taiwan Semi (TSM) and Intel's potential joint venture, as well as broader market sentiments influenced by U.S. chip manufacturing incentives. The CME Group stock rose 1.68% following a cooling of US consumer inflation, driven by falling gas prices, which eased concerns about immediate inflationary pressures and provided a more favorable outlook for the Federal Reserve's potential monetary policy decisions amidst tariff uncertainties. CME Group's stock price increased by 1.68% following an upgrade by Piper Sandler, which raised its price target from $275.00 to $283.00, reflecting increased investor confidence and suggesting an anticipated upside from the previous close. CME Group (CME) stock rose by 1.68% following the release of US consumer inflation data, which showed a cooling in inflation rates, particularly due to a significant drop in gas prices, easing concerns ahead of the potential impacts of President Trump's upcoming tariffs. The stock increase can be attributed to the positive inflation data, which suggests a reduced likelihood of immediate Federal Reserve interest rate cuts, thereby stabilizing financial markets. CME Group's stock rose by 1.68% following an upgrade by Morgan Stanley from "equal weight" to "overweight," which includes a price target of $301 that suggests an 18.44% potential upside, alongside several other positive ratings from research firms.
	2025-04-09	-0.35 %
CME Group's stock fell by 0.35% due to broader market concerns related to global economic volatility and uncertainty, potentially affecting investor sentiment.
	2025-04-08	+1.05 %
CME Group's stock rose 1.05% due to positive market sentiment surrounding the announcement of Cboe's upcoming launch of FTSE Bitcoin Index futures, which indicates ongoing innovation and interest in Bitcoin derivatives and aligns with the increasing integration of cryptocurrency into traditional financial markets. CME Group (CME) stock rose by 1.05% due to a combination of improving US stock market performance, particularly amid expectations of potential interest rate cuts by the Federal Reserve to stimulate growth and increased speculation on Bitcoin (BTC) benefiting from China's possible yuan devaluation, which traders see as a positive factor for risk assets. CME Group's stock rose by 1.05% following an increase in its target price by Barclays from $263.00 to $279.00 and positive ratings adjustments from several other analysts, indicating strong market confidence in the company's financial performance.
	2025-04-07	-0.82 %
CME Group's stock declined by 0.82% as global market turmoil fueled by US trade tariffs and negative sentiment in both cryptocurrency and traditional financial markets led to increased panic selling and fears reminiscent of historical market crashes.
	2025-04-04	-5.18 %
The CME Group (CME) stock fell by 5.18% due to market reactions to Federal Reserve Chair Jerome Powell's comments on the economic uncertainties posed by President Trump's tariffs, which are expected to raise inflation and slow growth, creating investor anxiety about future monetary policy. CME Group (CME) stock fell by 5.18% amid growing concerns over a potential recession sparked by President Trump's tariffs, which have led investors to anticipate aggressive interest rate cuts by the Federal Reserve despite ongoing inflationary pressures. The CME Group (CME) stock declined by 5.18% due to heightened fears of a prolonged US trade war and recession, which resulted in significant losses across US equities markets.
	2025-04-03	+2.22 %
The CME Group (CME) stock rose by 2.22% likely due to investor optimism stemming from anticipated interest rate cuts by the Federal Reserve, which could lead to improved conditions for small-cap stocks and overall market recovery. The CME Group (CME) stock rose 2.22% due to increased investor demand for liquid, low-risk assets like gold and Bitcoin amid macroeconomic uncertainty and high interest rates, leading to reallocation away from riskier investments such as U.S. stocks and altcoins.
	2025-04-02	+0.11 %
CME Group (CME) stock rose by 0.11% amidst a significant decline in US stock futures, as President Trump announced tariffs that are expected to heighten trade tensions and could lead to an economic recession, which may push investors towards safer asset classes like futures trading.
	2025-03-31	+1.17 %
The CME Group (CME) stock rose by 1.17% due to the positive sentiment in the market following Archax's acquisition of a U.S. broker-dealer, which signals increased institutional interest and regulatory clarity in the tokenization of assets.
	2025-03-28	+0.14 %
CME Group (CME) stock was up 0.14% due to positive market sentiments linked to the ongoing development and exploration updates at its flagship Nalunaq mine, where an increase in gold resource estimates demonstrates robust potential for growth and stability in mining operations.
	2025-03-27	-0.33 %
The CME Group (CME) stock fell by 0.33% as the company faces competition from financial giants like Intercontinental Exchange, which is exploring the integration of stablecoins and tokenized assets into their services, signaling a shift in the financial landscape towards digital currencies.
	2025-03-25	-0.33 %
CME Group Inc. is testing Google Cloud's blockchain technology to enhance market infrastructure amid the shift to 24/7 trading, but its stock fell by 0.33% likely due to market reactions to ongoing technological transitions and uncertainties surrounding the broader regulatory environment for digital assets.
	2025-03-21	-1.2 %
CME Group's stock declined by 1.2% following AlphaQuest LLC's dramatic reduction of its stake in the company by 98.9%, indicating potential investor concern over institutional selling, alongside mixed ratings from analysts which could impact investor sentiment.
	2025-03-19	-0.38 %
CME Group (CME) stock experienced a decline of 0.38% amid heightened market anxiety before the US Federal Reserve's interest-rate decision, as investors await potential comments from Fed Chair Jerome Powell that could influence risk assets like Bitcoin, which is currently under pressure. The CME Group (CME) stock fell by 0.38% amid growing concerns that economic policies and potential recession warnings from President Trump and his administration are shaking investor confidence on Wall Street. The decline in CME's stock is attributed to fears of an impending recession, as economic uncertainty increases and influential investors shift away from U.S. equities.
	2025-03-17	+1.89 %
The CME Group (CME) stock rose by 1.89% amid growing concerns about an economic slowdown and mixed signals regarding the potential for a recession, as investors may be seeking safer investments in response to increased market volatility and uncertainty surrounding U.S. economic policies. CME Group (CME) stock rose 1.89% as positive momentum in U.S. stocks and bullish sentiment in the broader crypto market, particularly from Bitcoin's surge, created a favorable environment for risk assets. CME Group (CME) stock rose by 1.89% last night, likely due to a broader recovery in the crypto market and positive trading sentiment following significant developments, such as the completion of the first-ever block trade in CME's SOL futures, which has sparked interest in the company's offerings.
	2025-03-14	-0.45 %
CME Group (CME) stock experienced a decline of 0.45% likely due to ongoing market volatility and regulatory uncertainties surrounding cryptocurrencies, despite an overall growing acceptance of digital assets in traditional finance.
	2025-03-13	+1.22 %
CME Group (CME) stock rose by 1.22% due to increased investor interest, as evidenced by a hedge fund, Jane Street Group LLC, boosting its stake in the Bitwise Bitcoin and Ether Equal Weight Strategy ETF, which is heavily invested in CME's Bitcoin and Ether futures contracts.
	2025-03-12	-1.42 %
CME Group's stock fell by 1.42% despite receiving an upgrade to "outperform" from Raymond James and various price target increases by other analysts, likely due to profit-taking after a recent climb in share value and insider selling.
	2025-03-11	-0.71 %
CME Group (CME) stock fell by 0.71% due to broader concerns regarding agricultural tariffs and their impact on farmers' profitability, which in turn affects related agricultural markets and associated stocks.
	2025-03-10	+3.03 %
The article discusses the potential reshuffle of the Greek government ahead of national elections, analyzing the implications of various ministerial changes and highlighting ongoing market activities, including the performance of CMC Group (CME) stock, which rose 3.03% due to investors' optimism related to upcoming government reforms and market dynamics. CME Group's stock increased likely due to positive sentiment surrounding government reforms and potential market opportunities, as well as optimism in the broader financial environment. CME Group (CME) stock saw a 3.03% increase amid growing market volatility and investors' expectations of potential Federal Reserve interest rate cuts, which could bolster the housing market by making borrowing cheaper. CME Group (CME) stock rose by 3.03% due to increased market volatility, which has led to higher trading activity on the platform.
	2025-03-07	+0.7 %
CME Group's stock rose by 0.7% following an increase in Q2 2025 earnings estimates by Zacks Research, which projected earnings per share to rise from $2.50 to $2.61 due to improved financial outlook and favorable earnings reports.
	2025-02-27	+0.75 %
CME Group Inc. (NASDAQ:CME) stock rose by 0.75% due to an increase in institutional investment, including a notable 7.9% position expansion by Private Advisor Group LLC, indicating strong confidence in the company's value after positive quarterly earnings results and a recently approved share repurchase program.
	2025-02-25	+1.24 %
CME Group (CME) stock rose by 1.24% due to the launch of a new suite of agricultural "micro" contracts aimed at attracting retail investors and supporting smaller farmers, thus enhancing opportunities in markets traditionally dominated by institutional players. CME Group Inc. (NASDAQ:CME) stock rose by 1.24% as institutional investors, including Atria Wealth Solutions, increased their stakes in the company, indicating strong investor confidence, alongside positive quarterly earnings results and a stock buyback plan supported by the board.
	2025-02-24	-0.45 %
CME Group (CME) stock recently experienced a decline of 0.45%, primarily due to external market pressures and uncertainties related to government actions and economic conditions.
	2025-02-20	-0.97 %
CME Group (CME) stock fell by 0.97% amid broader equity market declines and growing concerns over potential inflation from U.S. tariffs and immigration policies, as indicated by the Federal Reserve's recent meeting minutes.
	2025-02-18	+0.97 %
CME Group (NASDAQ:CME) stock rose 0.97% following a mix of institutional trading activity, including increases in holdings by several hedge funds, positive adjustments to price targets from multiple analysts, and better-than-expected quarterly earnings.
	2025-02-14	-1.85 %
CME Group (CME) stock fell by 1.85% due to disappointing retail sales data for January 2025, which showed a larger-than-expected decline, raising concerns about economic growth and potentially impacting GDP forecasts. CME Group Inc. (NASDAQ:CME) experienced a -1.85% decline in its stock price following a previous 52-week high, despite reporting better-than-expected quarterly earnings and announcing an increased dividend, likely due to profit-taking by investors after the stock's recent gains and mixed ratings from brokerage analysts.
	2025-02-12	+2.99 %
The CME Group (CME) stock rose by 2.99% last night, likely due to positive investor sentiment reflected in broader market trends, as well as sustained inflows into equity mutual funds, demonstrating confidence in the financial markets despite recent volatility. CME Group (CME) stock rose by 2.99% following a report of higher-than-expected inflation, which shifted market expectations regarding the Federal Reserve's interest rate cuts, leading traders to speculate that future cuts may be delayed. CME Group's stock rose 2.99% due to a favorable market sentiment and strong performance indicators from the broader financial markets, reflecting investor confidence amidst ongoing economic developments.
	2025-02-11	-0.03 %
CME Group's stock was down 0.03% ahead of its anticipated quarterly earnings report, reflecting cautious investor sentiment likely influenced by upcoming earnings expectations and mixed analyst ratings.
	2025-02-07	+0.17 %
CME Group Inc. (NASDAQ:CME) saw a 0.17% increase in its stock price, likely driven by institutional investments and a newly announced $3 billion share buyback plan, reflecting management's belief in the stock's undervaluation. CME Group Inc. (NASDAQ:CME) stock rose by 0.17% following an upward revision of its FY2026 earnings estimates by Zacks Research, which now anticipates earnings of $10.80 per share, indicating positive analyst sentiment and confidence in the company's financial performance. CME Group's stock rose by 0.17% due to increased institutional investments, notably a 37.4% stake increase by Spire Wealth Management, and the company's announcement of a $3 billion share buyback plan, which indicates confidence in the stock's value.
	2025-02-06	+1.15 %
CME Group's stock rose 1.15% amid ongoing market volatility caused by President Trump's tariff announcements, as investors reacted to potential changes in trade policies with mixed strategies, which included a significant level of trading activity in currencies and options markets. The increase in CME Group's stock can be attributed to heightened trading activity as investors sought to hedge or capitalize on the uncertainty surrounding tariffs and the broader market reaction to those developments. The CME Group (CME) stock rose by 1.15% last night, reflecting positive market sentiment which may be influenced by developments in the healthcare sector, such as Teladoc Health's acquisition of Catapult Health, highlighting investors' increasing interest in the health technology landscape.
	2025-02-03	+1.75 %
CME Group Inc. (NASDAQ:CME) experienced a 1.75% increase in its stock price, influenced by positive institutional investment activities, a rise in target price forecasts from several research firms, a substantial dividend payment, and a newly approved share buyback plan, suggesting confidence in the stock's value.
	2025-01-30	+1.47 %
CME Group (CME) stock rose by 1.47% in response to positive market conditions and investor anticipation regarding upcoming economic policies and developments, particularly around the Union Budget, which is expected to include measures that could invigorate growth and consumption.
	2025-01-27	+0.97 %
The CME Group (CME) stock rose by 0.97% as investors reacted to a general market decline driven by a sell-off in technology stocks following the demonstration of a competing AI chatbot from Chinese startup DeepSeek, which overshadowed concerns about U.S. tech companies despite their prevailing structural advantages in AI infrastructure. CME Group Inc. (NASDAQ:CME) saw its stock rise by 0.97% due to significant institutional investor interest, including a 15% increase in stake by Janney Montgomery Scott LLC, a stock buyback plan indicating management's belief in undervaluation, and a substantial increase in its dividend payout. The article reports that despite a tumultuous day for major tech stocks due to concerns over a new Chinese AI competitor, CME Group's stock rose 0.97% as investors possibly shifted towards safer investments amid the market's volatility and uncertainty surrounding AI technologies. CME Group (CME) stock rose 0.97% last night, likely due to its perceived stability and relative strength compared to the tumbling Big Tech stocks amid market turbulence caused by competition in the AI sector from a Chinese company.
	2025-01-24	+0.56 %
CME Group (CME) stock is up 0.56% due to the growing anticipation around the potential launch of XRP futures, which signals increased institutional interest and participation in the cryptocurrency market.
	2025-01-23	+0.37 %
U.S. stocks, including CME Group (CME), rose to record highs on Thursday, largely driven by stable Treasury yields and positive economic reports, which reassured investors and contributed to the stock's 0.37% increase. CME Group's stock rise can be attributed to the overall positive market sentiment and the expectation that the Federal Reserve will not cut interest rates, which can enhance investment valuations.
	2025-01-22	+0.12 %
CME Group Inc. (NASDAQ:CME) stock rose 0.12% as institutional investors, including Wealthcare Advisory Partners LLC, expanded their stakes in the company, reflecting confidence in its future performance amid a strong earnings report and a significant stock repurchase plan. CME Group Inc. (NASDAQ:CME) saw a slight 0.12% increase in its stock price, attributed to positive quarterly earnings exceeding analyst expectations, a significant increase in dividends, and a newly authorized stock buyback program signaling potential undervaluation.
	2025-01-21	-0.2 %
CME Group Inc. (NASDAQ:CME) stock fell by 0.2%, amidst mixed ratings from analysts and insider selling activity, despite an increase in institutional holdings and a stock buyback program indicating management's belief in the company's value.
	2025-01-17	+0.17 %
The article discusses Amir Baluch's insights on wealth-building strategies for physicians while highlighting how to leverage their medical careers for long-term financial stability through diversified investments and passive income streams. CME Group (CME) stock rose by 0.17% possibly due to positive market conditions or investor confidence in financial firms, influenced by discussions on wealth management and alternative investments.
	2025-01-15	-1.66 %
CME Group (CME) stock declined by 1.66% following a price target cut from $260.00 to $256.00 by Keefe, Bruyette & Woods, which issued a "market perform" rating amid mixed analyst reviews and general market sentiment affecting financial services stocks.
	2025-01-14	+0.99 %
CME Group's stock (NASDAQ:CME) rose by 0.99% following favorable analyst rating upgrades and announcements of a significant share buyback plan and dividend increase, which suggests confidence in the company's value and future performance. CME Group's stock rose 0.99% due to strong operating margins, a solid balance sheet, and confidence in its sustainable cash flow, especially following record revenues reported in October.
	2025-01-13	+0.11 %
CME Group (CME) stock rose by 0.11% amidst a mixed trading session, largely driven by investor sentiment influenced by rising bond yields and a stronger US dollar, as well as expectations regarding upcoming consumer inflation reports that are critical for monetary policy outlook. CME Group (CME) stock saw a 0.11% increase due to influential institutional investors increasing their positions, positive earnings reports exceeding estimates, and the announcement of a significant stock buyback program, indicating strong confidence in the company's value.
	2025-01-10	-0.04 %
CME Group (CME) stock declined by 0.04% amid a strong December jobs report that raised expectations for higher interest rates, reducing the likelihood of anticipated rate cuts from the Federal Reserve and creating a "good news is bad news" environment in the stock market. The CME Group (CME) stock went down primarily due to stronger-than-expected job growth, leading to fears of rising interest rates and diminishing hopes for rate cuts from the Federal Reserve. The CME Group (CME) stock was down 0.04% following stronger-than-expected December non-farm payrolls data, which indicated less likelihood of interest rate cuts from the Federal Reserve and led to a general selloff in the stock market due to rising inflation expectations. CME Group (CME) shares fell by 0.04% due to several institutional investors adjusting their positions, which indicates market volatility and uncertainty surrounding the stock's value amidst mixed analyst ratings.
	2025-01-08	+1.01 %
CME Group (CME) stock rose by 1.01% despite broader U.S. market declines influenced by inflation fears and rising Treasury yields, as strong signals of economic performance suggested potential for profit growth which could have positively impacted investor sentiment towards CME stocks.
	2025-01-07	+0.53 %
CME Group (CME) stock rose 0.53% as investors reacted to mixed economic data influencing market sentiments, particularly the anticipation of interest rate decisions from the Federal Reserve, which have shifted expectations regarding monetary policy easing. CME Group (NASDAQ:CME) stock rose by 0.53% despite Citigroup downgrading its rating from buy to neutral, while the stock's increase may be attributed to positive quarterly earnings results, a significant dividend increase, and an announced share buyback plan indicating that its leadership perceives the stock as undervalued.
	2025-01-06	-2.87 %
CME Group (CME) stock declined by 2.87% primarily due to a downgrade from analysts at Citigroup Inc., who changed their rating from buy to neutral and lowered the price target from $255.00 to $250.00. The CME Group (CME) stock fell by 2.87% due to a cautious investor sentiment influenced by a high interest rate environment, leading to a preference for "value storage assets" like government bonds over riskier investments, including riskier assets in both the crypto and traditional markets. CME Group's stock fell 2.87% following a restated "sector perform" rating from Royal Bank of Canada, which, despite suggesting a potential upside, reflects a cautious outlook amid multiple mixed ratings from other analysts, some of which indicated a sell or hold rating. CME Group (CME) stock declined by 2.87% due to a reiteration of its sector perform rating by Royal Bank of Canada, maintaining a price target of $235.00 for the stock.
	2024-12-31	+0.3 %
Despite a general decline in U.S. stocks, CME Group (CME) shares were up 0.3%, likely benefiting from ongoing investor interest driven by retail inflows into large-cap tech stocks and a broader marketplace buoyed by a strong year of trading, including significant gains from key sectors like artificial intelligence.
	2024-12-30	-0.84 %
CME Group (CME) stock experienced a decline of 0.84% due to the announcement that US stock markets, including the NYSE and Nasdaq, would close on January 9 in observance of a national day of mourning for former President Jimmy Carter, reflecting a tradition of halting trading following the death of a president, which may have contributed to negative sentiment in the market.
	2024-12-20	+0.72 %
CME Group Inc. (NASDAQ:CME) stock rose by 0.72% due to a combination of positive analyst upgrades, a robust quarterly earnings report that exceeded expectations, the initiation of a significant stock repurchase plan indicating management's belief in the stock's value, and an increase in its dividend payout. The CME Group (CME) stock experienced a 0.72% increase due to a broader rally on Wall Street, driven by better-than-expected inflation data that eased concerns about aggressive interest rate cuts by the Federal Reserve, leading traders to adjust their expectations for the central bank's future actions. CME Group (CME) stock rose by 0.72% following a general increase in U.S. stocks, which was driven by better-than-expected inflation data that eased concerns about rising interest rates, leading traders to adjust their bets on future rate cuts.
	2024-12-19	-0.11 %
CME Group's stock declined by 0.11% amid a broader market downturn following the Federal Reserve's indication of fewer interest rate cuts than previously expected, which dampened investor enthusiasm and led to a mixed response in the markets. CME Group (CME) stock fell by 0.11% amid broader market instability following the Federal Reserve's indication that it may implement fewer interest rate cuts than anticipated next year, which has dampened trader expectations and market enthusiasm. CME Group (CME) stock experienced a -0.11% decline amid a broader market slowdown following the Federal Reserve's indications of potentially fewer interest rate cuts than previously expected, leading to concerns about the economic outlook and investment climate. CME Group (CME) stock fell by 0.11% due to shifting investor sentiment regarding future interest rate cuts by the Federal Reserve, with increased concerns that the central bank may not lower rates as expected and could potentially raise them, influenced by stronger economic growth and rising inflation.
	2024-12-18	+0.46 %
The CME Group (CME) stock rose by 0.46% despite a broader market decline driven by the Federal Reserve's unexpected hawkish tone on future monetary policy, which disappointed investors anticipating more aggressive rate cuts. The rise in CME Group's stock can be attributed to its potential benefits from the volatility created in the markets due to interest rate changes and its position as a major player in derivatives trading, which often thrives in uncertain economic climates.
	2024-12-17	+0.03 %
CME Group (CME) stock increased by 0.03% last night, likely due to positive trading sentiment and investor confidence amidst an overall mixed performance in the stock market. CME Group (CME) stock rose by 0.03% as optimism surrounding a likely Federal Reserve interest rate cut boosted investor confidence. The increase in CME's stock can be attributed to positive market sentiment fueled by the expectation of a quarter percentage point interest rate cut, which is anticipated to stimulate economic growth and encourage trading activity in the financial markets.
	2024-12-16	-0.54 %
CME Group (CME) stock declined by 0.54%, influenced by mixed economic indicators, persistent inflation, and uncertainty regarding interest rate cuts, which have left investors cautious about market conditions. The downturn in CME's stock might be attributed to broader market volatility and investor concerns about inflationary pressures impacting future economic growth.
	2024-12-12	+0.7 %
CME Group (CME) stock rose 0.7% possibly due to market expectations of a Federal Reserve interest rate cut, despite mixed signals on inflation and increasing unemployment claims, suggesting that investors may be optimistic about a more accommodative monetary policy. CME Group (CME) stock rose 0.7% as markets anticipate a Federal Reserve interest rate cut next week despite mixed inflation data, reflecting concerns over the labor market and economic conditions.
	2024-12-10	+1.04 %
CME Group Inc. (NASDAQ:CME) stock rose by 1.04% last night, influenced by a combination of institutional investment activities, the announcement of a substantial share buyback plan indicating perceived undervaluation, and a robust quarterly earnings report exceeding analyst expectations. CME Group's stock rose by 1.04% following an increase in its price target by Barclays from $231.00 to $257.00, signaling positive sentiment among analysts about the company's financial performance and prospects.
	2024-12-09	-1.11 %
CME Group (CME) stock was down 1.11% last night due to the negative sentiment in the broader crypto market, characterized by decreased prices for major cryptocurrencies like Bitcoin and Ethereum, as investors appear to be in a profit-taking phase amid signs of a potential peak in the current bullish cycle.
	2024-12-06	-2.7 %
CME Group (CME) stock fell by 2.7% due to mixed employment data that heightened uncertainty about future interest rate cuts by the Federal Reserve, despite overall positive trends in the U.S. stock market. CME Group (CME) stocks fell by 2.7% amid mixed performance in US markets as stronger job data raised confidence in the economy but also fueled speculation about potential interest rate cuts by the Federal Reserve, leading to investor uncertainty. CME Group's stock (CME) fell by 2.7% as overall market sentiment remained mixed, with significant pressure from the Dow Jones Industrial Average's decline and uncertainty surrounding potential Federal Reserve rate cuts amidst fluctuating economic indicators.
	2024-12-04	+0.94 %
The CME Group (CME) stock rose 0.94% due to a broader tech rally that propelled U.S. stocks to record highs, bolstered by positive remarks from Federal Reserve Chair Jerome Powell about the strong state of the U.S. economy and expectations for interest rate cuts later this month. CME Group (CME) stock rose by 0.94% following a tech rally that lifted US stocks to record highs, bolstered by Federal Reserve Chair Jerome Powell's optimistic remarks on the economy, which fueled investor confidence for an anticipated interest rate cut in December.
	2024-12-02	-1 %
CME Group Inc. (NASDAQ:CME) stock fell by 1.0% due to a combination of recent insider selling, fluctuating analyst ratings, and slight revenue miss in its quarterly earnings report, despite an increase in EPS compared to the previous year.
	2024-11-29	+0.28 %
CME Group (CME) stock increased by 0.28% amid a broader market rally driven by record highs in the S&P 500 and Dow Jones Industrial Average, bolstered by strong performance in technology and retail sectors as consumers responded positively to deep Black Friday discounts. The rise in CME Group's stock can be attributed to overall market optimism following robust consumer spending estimates for the holiday shopping season, alongside favorable conditions in related sectors such as technology, which enhanced investor sentiment.
	2024-11-27	+1.25 %
The article discusses the occurrence of a geomagnetic storm caused by a coronal mass ejection (CME) from the sun, which is expected to create auroras visible as far south as New York and Idaho. The CME Group (CME) stock likely rose by 1.25% due to positive market sentiment surrounding the potential increased visibility of northern lights, which may drive interest and engagement in sectors related to space weather monitoring and tourism.
	2024-11-22	+1.09 %
CME Group Inc. (NASDAQ:CME) stock rose 1.09% due to positive earnings results that exceeded consensus estimates and strong institutional investor interest, as reflected by significant increases in holdings by several hedge funds.
	2024-11-21	-0.63 %
The CME Group (CME) stock fell by 0.63% due to overall market volatility and sell-offs in significant stocks during trading, particularly in companies linked with the Adani Group facing severe allegations, which negatively impacted investor sentiment. CME Group's stock was down 0.63% amid a broader market rally as investor sentiment turned positive following strong performances from major companies like Nvidia and Salesforce, despite concerns about economic indicators and regulatory challenges facing other tech giants like Alphabet and Amazon. CME Group's stock decline may be attributed to broader market trends rather than specific negative news about the company, as it was influenced by fluctuations in investor sentiment, upcoming Federal Reserve announcements, and geopolitical tensions, which might have overshadowed its own performance. CME Group's stock declined by 0.63% following a report that OneDigital Investment Advisors LLC reduced its position in the company by 11.2% during the third quarter, amidst broader market fluctuations influenced by institutional trading activity and varying analyst ratings.
	2024-11-20	-0.72 %
The CME Group (CME) stock declined by 0.72%, influenced by broader market movements where tech stocks like Nvidia reported mixed earnings and Target's disappointing outlook prompted concerns about consumer spending, impacting investor sentiment.
	2024-11-18	+1.01 %
CME Group (CME) stock rose by 1.01% due to its resilience amidst overall market declines, bolstered by a recovery in investor sentiment linked to strong performances in certain sectors, despite ongoing foreign fund outflows and weakness in technology stocks.
	2024-11-15	+0.83 %
CME Group Inc. (NASDAQ:CME) stock rose 0.83% due to a combination of positive quarterly earnings results exceeding analysts' expectations, recent institutional buying activity, and a favorable forecast from Piper Sandler increasing its price target, despite some insider selling.
	2024-11-14	-2.07 %
CME Group (CME) stock fell by 2.07% due to overall market declines driven by foreign institutional investor selling, disappointing quarterly earnings reports, and rising inflation concerns, which also affected broader indices like the BSE Sensex and NSE Nifty.
	2024-11-13	+0.81 %
CME Group (CME) stock rose 0.81% amid positive investor sentiment following a US inflation report that aligned with expectations, which increased hopes for potential interest rate cuts by the Federal Reserve next month, enhancing market confidence.
	2024-11-12	+0.17 %
The article discusses Colt Technology Services' major expansion of its capital markets data solutions to include access to data from the NYSE and NASDAQ, which is expected to enhance its offerings and could contribute to the rise in CME Group (CME) stock by fostering greater market engagement and potential growth opportunities in the capital markets sector. CME Group (CME) stock rose by 0.17% likely due to strong quarterly earnings results that exceeded expectations, an increase in revenue, and upcoming dividend announcements, despite some institutional investors adjusting their stakes.
	2024-11-08	+1.63 %
CME Group Inc. (NASDAQ:CME) experienced a 1.63% increase in stock price due to several recent positive analyst upgrades, increased institutional investor activity, and strong earnings performance, despite some hedge funds reducing their stakes. CME Group's stock rose 1.63% following news of increased institutional investments and positive quarterly earnings results, which surpassed analyst estimates and indicated a strong revenue growth compared to the previous year. CME Group (CME) stock rose 1.63% following the Federal Reserve's decision to cut interest rates by 25 basis points, indicating market optimism despite uncertainties around future economic policies from the upcoming president-elect. The increase in CME's stock price can be attributed to the anticipated benefits of lower interest rates, which often stimulate trading activity and positively affect market sentiment.
	2024-11-07	+0.39 %
CME Group (CME) stock rose by 0.39% as investors reacted positively to the potential economic impacts of Donald Trump's return to the White House, anticipating policies that could lead to stronger economic growth despite concerns about trade tensions and inflation.
	2024-11-06	-1.79 %
The CME Group (CME) stock fell by 1.79% amid a broader market surge following Donald Trump's electoral success, as investors reacted to potential policy shifts that could lead to higher inflation and uncertainty for certain sectors, particularly those reliant on lower tariffs and regulations. The drop in CME's stock is likely influenced by concerns that Trump's policies may disrupt the market environment, particularly affecting forecasts for interest rates and inflation, which are pivotal to CME's operations in futures and options trading. CME Group (CME) stock declined by 1.79% amid rising concerns over potential inflation and higher tariffs under Donald Trump's new presidency, which led to increased Treasury yields and a more uncertain economic outlook. CME Group (CME) stock declined by 1.79% amid a broader market rally driven by expectations of stronger economic growth under Donald Trump's potential return to the White House, which has increased concerns about rising inflation and interest rates affecting financial sector stocks, including CME. The CME Group (CME) stock fell by 1.79% as the broader U.S. stock market experienced a rally following Donald Trump's electoral win, which shifted investor sentiment and led to increased concerns about inflation and higher tariffs impacting various sectors, including those associated with CME's operations.

1
500 / page